In the Final Round of Harris vs. Trump: Who is Better for IP Rights?The future of intellectual property rights under the incoming administration remains uncertain and heavily dependent on political perspectives.
Gamechanger' HIV prevention drug to be made available cheaply in 120 countriesGilead has agreed to make lenacapavir available cheaply in 120 countries, but many high-HIV burden nations are excluded, creating access issues.
Medicare drug price negotiations: Here's a savings breakdownMedicare recipients will save $1.5 billion on medication costs starting in 2026 through negotiated drug prices.